Furthermore, Yang et al. suggested that the activation of signal cointegrator 1 complex subunit 2 (ASCC2), solute carrier family 25 member 37 (SLC25A37), and leucine rich repeat containing 18 (LRRC18), can be used as diagnostic markers of CAD, while immune cell infiltration plays a crucial role in the occurrence and development of CAD [10]. This evidence concerns the gene LRRC18 and coronary artery disorder.